US 11162076
Methods and compositions for inducing hematopoietic cell differentiation
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11162076 (Methods and compositions for inducing hematopoietic cell differentiation) held by Fate Therapeutics, Inc. expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K35/28, A61K35/545